Hope is the belief that a positive outcome is possible, while optimism is the expectation that it is probable. Maintaining hope provides motivation to act, but avoiding optimism prevents complacency and allows for contingency planning for negative outcomes. This distinction is crucial for navigating volatile situations.

Major life decisions like career paths, marriage, or having children are not made based on a scientific assessment of success odds. Instead, they are acts of faith, guided by what we allow ourselves to hope for, even when the data suggests the path is difficult.

People feel better after buying insurance not just because of financial protection, but because it transforms anxiety-inducing uncertainty (not knowing what might happen) into manageable risk (assigning probabilities to known outcomes). This shift alleviates misery.

A $2,000 preventative injection like a PCSK9 inhibitor sounds expensive. However, its cost is likely justified when calculated against the massive societal and individual expense of future medical bills, plus the economic value of additional healthy, productive years.

During the COVID pandemic, some people drank bleach because our brains are wired to despise uncertainty. In the absence of clear answers, we gravitate towards any promised solution, however dangerous, because taking action provides a false sense of control.

Treating genetic testing as a "magic" or specialized service reserved for counselors has caused a 30-year disservice to patients. This fear and hesitation has led to an estimated 38,000 missed opportunities annually to identify hereditary risk, resulting in larger cancers, harsher treatments, and more deaths.

Economics-based rational choice theory frames decisions as a calculation of "expected utility," multiplying value by probability. This analogizes complex life choices—from careers to partners—to casino bets, oversimplifying non-quantifiable factors and reducing judgment to mere calculation.

Polygenic embryo screening, while controversial, presents a clear economic value proposition. A $3,500 test from Genomic Prediction that lowers Type 2 Diabetes risk by 12% implies that avoiding the disease is worth over $27,000. This reframes the service from 'designer babies' to a rational financial decision for parents.

The economic value of extending healthy life is astronomical. One research team estimated a single year of added healthspan is worth $38 trillion to the US economy, a figure experts believe is still an underestimate. This reframes geroscience investment as a massive economic opportunity, not a cost.